Could your own lung cells heal damaged airways? a new trial aims to find out
NCT ID NCT06987214
First seen Jul 20, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This early-phase trial is testing whether a stem cell therapy called REGEND001 can safely repair damaged lung tissue in adults with bronchiectasis, a chronic lung condition. The treatment uses a patient's own regenerative lung cells, which are collected, multiplied in a lab, and then infused back into the lungs. The study will measure changes in lung function, imaging, and quality of life, with a focus on safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a stem cell therapy made from the patient's own lung cells, called REGEND001
- What this could lead to
- If successful, this approach could offer a new way to repair damaged lungs in people with bronchiectasis, potentially improving breathing and quality of life.
- What could go wrong
- This is an early phase 1 trial with only 10 participants, so it is primarily testing safety. The treatment may not improve lung function, and there are risks from the bronchoscopic procedures and cell infusion.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIECTASIS ADULT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ruijin Hospital Hainan Branch, Shanghai Jiao Tong University School of Medicine
RECRUITINGQionghai, Hainan, 571437, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200025, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breathing and qigong: a drug-free approach to easier breathing for damaged lungs?
- New drug CTX-187 takes aim at stubborn bacterial infections
- Lung patients may soon do rehab from home via app
- New study aims to find best exercise test for lung disease patients
- 500 patients to test if daily azithromycin keeps bronchiectasis attacks at bay
- Yoga from home may ease breathing problems in lung disease patients